bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
All Web sites
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2014: A J J M A M F J
2013: D N O S A

 
  Other news for:
Alzheimer Disease
 Resources from HONselect
Eye Tests Might Help ID Alzheimer's, Studies Suggest
Researchers report on two approaches that look for telltale plaques

By Robert Preidt

SUNDAY, July 13, 2014 (HealthDay News) -- Eye tests could be used to identify people in the early stages of Alzheimer's disease, two new studies suggest.

In one study, early results from 40 participants who used a certain eye test found a significant association between levels of beta-amyloid plaques in the retina of the eye and levels of the plaques in the brain. Beta-amyloid plaques in the brain are associated with Alzheimer's disease.

This type of eye test could be used in conjunction with the brain scans and clinical tests currently relied on to diagnose Alzheimer's, study author Shaun Frost, of the Commonwealth Scientific and Industrial Research Organization in Australia, said in a news release from the Alzheimer's Association.

The eye test could also be used to monitor the progression of Alzheimer's and a patient's response to treatment, Frost added.

The preliminary results were scheduled for release at the annual meeting of the Alzheimer's Association in Copenhagen, Denmark, which started Sunday. The full study, involving 200 participants, is expected to be completed later this year.

Another study presented at the meeting utilized a different type of eye test. It found a strong link between levels of beta-amyloid plaques in the lens of the eye and in the brain.

"There is a critical need for a fast, dependable, low-cost and readily available test for the early diagnosis and management of Alzheimer's disease," Dr. Pierre Tariot, director of the Banner Alzheimer's Institute in Phoenix, Ariz., said in an Alzheimer's Association news release. Tariot was a principal investigator in the study.

Research presented at meetings is considered preliminary until published in a peer-reviewed medical journal.

More information

The U.S. National Library of Medicine has more about Alzheimer's disease.

SOURCE: Alzheimer's Association, news release, July 13, 2014

Copyright © 2014 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=689459

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Eye
Id
Association
Brain
Research Personnel
Alzheimer Disease
Therapeutics
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact